News Summary

Nutrix, a Swiss health tech startup, is making waves with its newly launched device, cortiSense, which measures cortisol levels in saliva to monitor stress. Backed by the Mayo Clinic, this innovative hardware has already won the CES Innovation Award 2025 in the Digital Health category. Nutrix’s CEO, Maria Hahn, highlights the importance of tracking cortisol levels throughout the day, which is crucial for mental and metabolic health. The startup has raised $4 million to date, including a $2.5 million seed round co-led by Simpact and OIST-Lifetime Ventures. Nutrix is now seeking a Series A round to fund its expansion, particularly in the U.S., where it plans to open offices in Silicon Valley. With its gSense platform integrated into Chile’s public insurance system, Nutrix has also expanded operations to Mexico and Peru. The company focuses on corporate health screenings, which are more prevalent outside the U.S. Nutrix aims to address the economic impact of workplace stress while ensuring private health data remains confidential.